1. Home
  2. ATCH vs ARTL Comparison

ATCH vs ARTL Comparison

Compare ATCH & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • ARTL
  • Stock Information
  • Founded
  • ATCH 2022
  • ARTL 2011
  • Country
  • ATCH United States
  • ARTL United States
  • Employees
  • ATCH N/A
  • ARTL 6
  • Industry
  • ATCH
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATCH
  • ARTL Health Care
  • Exchange
  • ATCH Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • ATCH 3.4M
  • ARTL 3.1M
  • IPO Year
  • ATCH N/A
  • ARTL N/A
  • Fundamental
  • Price
  • ATCH $0.42
  • ARTL $1.07
  • Analyst Decision
  • ATCH
  • ARTL Strong Buy
  • Analyst Count
  • ATCH 0
  • ARTL 2
  • Target Price
  • ATCH N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • ATCH 653.2K
  • ARTL 1.2M
  • Earning Date
  • ATCH 05-27-2025
  • ARTL 05-12-2025
  • Dividend Yield
  • ATCH N/A
  • ARTL N/A
  • EPS Growth
  • ATCH N/A
  • ARTL N/A
  • EPS
  • ATCH 2.67
  • ARTL N/A
  • Revenue
  • ATCH N/A
  • ARTL N/A
  • Revenue This Year
  • ATCH N/A
  • ARTL N/A
  • Revenue Next Year
  • ATCH N/A
  • ARTL N/A
  • P/E Ratio
  • ATCH $0.16
  • ARTL N/A
  • Revenue Growth
  • ATCH N/A
  • ARTL N/A
  • 52 Week Low
  • ATCH $0.42
  • ARTL $0.82
  • 52 Week High
  • ATCH $84.00
  • ARTL $1.59
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 29.02
  • ARTL 56.02
  • Support Level
  • ATCH $0.48
  • ARTL $1.00
  • Resistance Level
  • ATCH $0.60
  • ARTL $1.16
  • Average True Range (ATR)
  • ATCH 0.07
  • ARTL 0.13
  • MACD
  • ATCH 0.07
  • ARTL 0.02
  • Stochastic Oscillator
  • ATCH 5.45
  • ARTL 42.24

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: